Neuroscientific Biopharmaceuticals Ltd. has released a press release.
2026 Annual Report & Appendix 4E
Earlier from Neuroscientific Biopharmaceuticals
- Remarkable Results from Patients treated with StemSmart
- Half Yearly Report and Accounts
- Quarterly Activities/Appendix 4C Cash Flow Report
- Successful Clinical Results Achieved under Special Access